IT Tech Packaging, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ITP research report →
Price Chart
About the company
IT Tech Packaging, Inc. operates within the People's Republic of China, focusing on the manufacturing and distribution of a diverse array of paper and related products. The company supplies corrugating medium papers, which are utilized by businesses in the production of corrugated cardboard, and also provides offset printing papers to printing establishments.
- CEO
- Zhenyong Liu
- IPO
- 2007
- Employees
- 383
- HQ
- Baoding, HE, CN
Get TickerSpark's AI analysis on ITP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.98M
- P/E
- -0.28
- PEG
- 0.04
- P/S
- 0.05
- P/B
- 0.01
- EV/EBITDA
- 0.89
- Div Yield
- 0.00%
- Gross Margin
- 5.51%
- Op Margin
- -10.01%
- Net Margin
- -11.26%
- ROE
- -4.53%
- ROIC
- -3.78%
Latest fiscal year · YoY change
- Revenue
- $75.84M-12.4%
- Gross Profit
- $6.69M+569.3%
- Op Income
- $-8,210,718
- Net Income
- $-9,843,094+1.0%
- EPS
- $-0.98+1.0%
- OCF Growth
- -51.1%
- FCF Growth
- +163.4%
- 52W High
- $0.39
- 52W Low
- $0.16
- 50D MA
- $0.18
- 200D MA
- $0.20
- Beta
- -0.24
- RSI (14)
- 49
- Avg Volume
- 807.07K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
IT Tech Packaging reported sharply higher 2021 revenue and profit, driven by stronger CMP pricing and volumes, while fourth-quarter results also showed continued margin improvement.· March 15, 2022
- FY2021 revenue rose 59.4% to $160.9 million and gross profit increased 93.2% to $11 million.
- Q4 revenue increased 38.7% to $45.1 million; Q4 net income was $4.2 million, or $0.07 per share, versus a $1.6 million loss a year ago.
- CMP remained the core engine, generating $39.7 million in Q4 revenue and $134.5 million for the year, supported by higher ASPs and volume growth.
- SG&A fell 12% in Q4 and 14.3% for the year, helping operating income turn positive.
- Liquidity improved materially, with working capital rising to $35.1 million at year-end 2021 from a $3.4 million deficit in 2020.
Fourth-quarter 2021 total revenue increased 38.7% year over year to $45.1 million. Q4 gross profit was $4.3 million versus $0.7 million a year ago; net income was $4.2 million, or $0.07 per basic and diluted share, versus a net loss of $1.6 million, or $0.06 per share. Q4 EBITDA rose to $8.7 million from $2.6 million. For fiscal 2021, revenue rose 59.4% to $160.9 million, gross profit increased 93.2% to $11 million, gross margin was 6.9% versus 5.7% a year ago, net income was $0.9 million, or $0.02 per share, and EBITDA increased to $22.9 million from $10.2 million. Management did not provide explicit next-quarter or full-year 2022 guidance on this call, but said it was excited about the momentum heading into the first quarter and year ahead.
The CEO emphasized that 2021 was a strong execution year, highlighting rapid revenue growth, improved business efficiency, and a better revenue mix. He pointed to initiatives to optimize revenue structure and diversify the business, including investments in demand generation and customer loyalty. His tone was confident and upbeat, saying the company exceeded its 2021 objectives and expects its fundamentals to support long-term growth.
The CFO walked through a detailed quarter and full-year bridge, citing higher CMP volumes and ASPs as the main drivers of growth. In Q4, CMP revenue was $39.7 million, regular CMP ASP rose 30.8% to $569 per tonne, and light-weight CMP ASP rose 32.2% to $558 per tonne; for the full year, CMP revenue was $134.5 million and CMP volume increased 31.9% to 259,691 tonnes. She also noted SG&A declined 12% in Q4 to $2.4 million and was $9.6 million for the year, while working capital improved to $35.1 million with cash and bank balances of $11.2 million, short-term debt of $13.5 million, and long-term debt of $3 million.
There was no analyst Q&A segment in the transcript, so no specific questions or management rebuttals were raised on the call. The most notable points came from prepared remarks only: management highlighted rising CMP pricing, improving margins, and stronger liquidity, but did not provide 2022 guidance or comment on detailed near-term demand trends beyond expressing optimism about the first quarter and the year ahead.
The call showed a clear improvement in profitability, with both quarterly and full-year revenue and gross profit growing sharply and operating income turning positive. Management also pointed to higher CMP prices and volumes, lower SG&A, and a much stronger working-capital position, which suggests better operating leverage and financial flexibility.
The company did not offer formal forward guidance for next quarter or full year, limiting visibility into 2022. Some businesses were weaker, including offset printing paper and tissue in Q4, and the company still carried debt and had negative operating cash flow of $2.4 million for 2021.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 96.8%
- Shares Outstanding
- 16.97M
- Float Shares
- 16.42M
of shares held by institutions
13 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Hoover Financial Advisors, Inc. | 500 | 0 |
Held by 6 ETFs
Biggest fund positions in ITP by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 8, 20 | LIU ZHENYONG | other | 200,000 |
| May 23, 19 | LIU ZHENYONG | sell | 324,326 |
| May 23, 19 | HAO JING | sell | 4,000 |
| Sep 17, 18 | HAO JING | other | 10,000 |
| Sep 17, 18 | LIU ZHENYONG | other | 200,000 |
| Jan 12, 16 | Wang Wenbing | other | 5,000 |
| Jan 12, 16 | LIU ZHENYONG | other | 200,000 |
| Jan 12, 16 | KU HON WAI | other | 7,500 |
| Nov 3, 14 | KU HON WAI | other | 0 |
| Nov 3, 14 | HAO JING | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ITP coverage
Recent articles, reports, and earnings notes.
No research on ITP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ITP report →Press Release: Sanofi's Wayrilz approved in Japan to treat immune thrombocytopenia
globenewswire.com · Jun 23
Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026
globenewswire.com · Jun 11
IT Tech Packaging, Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements
prnewswire.com · Apr 20
IT Tech Packaging (NYSE:ITP) Shares Up 5% – Should You Buy?
defenseworld.net · Dec 17
IT Tech Packaging, Inc. Announces Results of 2025 Annual General Meeting of Stockholders
prnewswire.com · Oct 31
IT Tech Packaging, Inc. Provides Response to Unusual Market Action
prnewswire.com · Sep 11
IT Tech Packaging, Inc. to Hold Annual General Meeting of Stockholders on October 31, 2025
prnewswire.com · Sep 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.